Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Apr 16;10(2):e00446-19. doi: 10.1128/mBio.00446-19

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Crown copyright 2019.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

PMC Copyright notice

FIG 3 — In vitro antimicrobial susceptibility. (A) MIC distributions for 13 antimicrobial agents against 185 C. difficile. VAN, vancomycin; MTZ, metronidazole; FDX, fidaxomicin; RFX, rifaximin; AMC, amoxicillin-clavulanate; CLI, clindamycin; ERY, erythromycin; CRO, ceftriaxone; MEM, meropenem; MXF, moxifloxacin; TET, tetracycline; TZP, piperacillin-tazobactam; TMP, trimethoprim. Where available, established susceptible and resistant breakpoints are indicated by vertical green and red lines, respectively. (B) Plots showing overall percentage of nonsusceptibility and percentage of phenotypic-genotypic concordance for the TetR (tetracycline-resistant), FQR (fluoroquinolone-resistant), and MLS_B (macrolide-lincosamide-streptogramin B-resistant) phenotypes.